Peter Ricci

TL;DR: In a cohort of patients with grade 2 glioma who were younger than 40 years of age and had undergone subtotal tumor resection or who were 40 yearsof age or older, progression-free survival and overall survival were longer among those who received combination chemotherapy in addition to radiation therapy than amongThose who received radiation therapy alone.

TL;DR: The data suggest that the ability of FDG PET to differentiate recurrent tumor from radiation necrosis is limited, and both false-positive and false-negative PET scan results contributed to unacceptably low sensitivity and specificity values.

TL;DR: Test the hypothesis that the accuracy of single-voxel MR spectroscopy in the categorization of lesions as either tumor or not tumor is dependent on voxel position and found that spectra obtained from voxels at the enhancing edge of a tumor more accurately reflect lesion histopathology than do specta obtained from the lesion center, even if the centrally placed voxela contain solidly enhancing tissue.

TL;DR: Long term follow up results for PCV given with RT at the time of initial diagnosis prolongs progression-free survival (PFS), but not overall survival (OS), compared with RT alone are reported.

TL;DR: The observed benefit is most definitive for O and OA patients, and the log rank test is used to compare survival and progression free survival (PFS) distributions for each histologic type.